According to Israeli media, the government has issued an additional seven medical cannabis cultivation licenses. This decision will result in the tripling of the amount of medical cannabis grown in the country.
The seven companies granted cultivation licenses are Elpis Flora, Briev Agricultural Crops, Medical Cannabis Growing, Rami Sela, Shavit Agro, Natali Buskila and S. Sydan. It is expected that these seven entities will be in position to avail medical cannabis products to Israeli pharmacies by the end of this year.
This week also marks the overhaul of the medical cannabis program in Israel as new regulations come into force. These regulations require medical cannabis producers to sell their products to licensed medical cannabis pharmacies instead of selling those products directly to certified patients. This move has added the layer of a middleman (the pharmacies) to the industry.
To make the transition smooth, regulators have said that starting with September, medical cannabis producers in the country will be expected to sell at least 10 percent of what they produce to pharmacies.
The volume sold to pharmacies must increase by 10 percent every month so that come January 2020, the entire volume of products grown by licensed cultivators is sold to pharmacies.
Read more at CNW420